Daiichi Sankyo and GAIA join forces to commercialise digital therapeutic for high cholesterol
Daiichi Sankyo Europe and Gaia announced a partnership to commercialize Gaia's digital therapeutic for high cholesterol, marking a new market entry for the product.
Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology
Daiichi Sankyo to Merge with Wholly Owned Subsidiary Daiichi Sankyo Propharma
AstraZeneca and Daiichi Sankyo Enter Global Collaboration to Jointly Develop and Commercialize Enhertu
Daiichi Sankyo's European division is teaming up with German medtech Gaia to sell the latter company's cardiovascular digital therapeutic.
Where this signal fits in the broader landscape.
https://www.medicaldevice-network.com/news/daiichi-sankyo-gaia-digital-health-tool-lipodia-cardiovascular/
Read Full SourceGet curated intelligence delivered to your inbox. No spam, unsubscribe anytime.
Sign in to save notes on signals.
Sign In